Spots Global Cancer Trial Database for hPG80 (Circulating Progastrin) as a Blood Biomarker for High-grade Glial Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: hPG80 (Circulating Progastrin) as a Blood Biomarker for High-grade Glial Tumors
Official Title: Pilot Study of hPG80 (Circulating Progastrin) as a Blood Biomarker for High-grade Glial Tumors
Study ID: NCT05157594
Conditions
Interventions
Study Description
Brief Summary: PROGLIO is a French mono-centric study with longitudinal follow-up, in which patients with high grade brain tumors will be included. Blood samples will be taken during their therapeutic follow-up to evaluate plasma concentrations of hPG80 (circulating progastrin).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Centre Jean PERRIN, Clermont-Ferrand, , France
Contact Details
Name: Xavier DURANDO, Pr
Affiliation: Centre Jean Perrin
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
